BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7940813)

  • 1. Cyclosporine monotherapy in children: long-term effect.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2610-6. PubMed ID: 7940813
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 3. Protocol biopsies in stable renal transplant patients under triple immunosuppression: results at 6 months.
    Rush DN; Jeffery JR; Gough J
    Transplant Proc; 1994 Oct; 26(5):2576. PubMed ID: 7940797
    [No Abstract]   [Full Text] [Related]  

  • 4. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A; Sells RA; Bakran A; Tewari A
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract]   [Full Text] [Related]  

  • 5. Kidney transplantation from living donors in Hungary: experience of 22 years.
    Perner F; Hidvégi M; Járay J; Alföldy F; Gyódi E; Petrányi G
    Transplant Proc; 1996 Dec; 28(6):3584-90. PubMed ID: 8962389
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of hypertension, hyperlipidemia and cyclosporine A therapy on long-term renal allograft survival.
    Maeda H; Sakamoto K; Kashiwabara H; Hachisu T; Yamada H; Matsushita K; Yamada K; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1633-4. PubMed ID: 8658816
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney transplantation from older ( > or = 55 years) donors: a risk factor for graft survival.
    Mizutani K; Katoh N; Yamada S; Ono Y; Takeuchi N; Matsuura O; Ohshima S
    Transplant Proc; 1996 Jun; 28(3):1589-90. PubMed ID: 8658797
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated acute rejection in renal allograft.
    Han DJ; Yoon HS; Lee HM
    Transplant Proc; 1996 Jun; 28(3):1455. PubMed ID: 8658738
    [No Abstract]   [Full Text] [Related]  

  • 11. Posttransplant serum creatinine area under the curve predicts renal allograft outcome.
    Sumrani N; Hong J; Miles A; Markell M; Distant D; Fleishhacker J; Maursky V; Jean-Baptiste F; Sommer B
    Transplant Proc; 1996 Feb; 28(1):356-7. PubMed ID: 8644260
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric renal transplantation: personal experience.
    Berloco P; Pretagostini R; Poli L; Rossi M; Iappelli M; Di Nicuolo A; Venettoni S; De Simone P; Cancrini C; Novelli G; Alfani D; Cortesini R; Lubrano R; Castello MA
    Transplant Proc; 1996 Feb; 28(1):282-3. PubMed ID: 8644225
    [No Abstract]   [Full Text] [Related]  

  • 13. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
    Sugito K; Morozumi K; Oikawa T
    Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic rejection in 500 kidney transplant patients treated with cyclosporine: incidence and risk factors.
    Pallardó LM; Sánchez J; Puig N; Sánchez P; Beneyto I; Crespo J; Ros F; Rochera A
    Transplant Proc; 1995 Aug; 27(4):2215-6. PubMed ID: 7652778
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function.
    Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG
    Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraoperative renal biopsy and its relation to renal function at the end of the first year posttransplantation.
    Vazquez MC; Schiavelli RO; Sabbatiello R; Castiglioni T; Pattin M
    Transplant Proc; 1996 Feb; 28(1):372-3. PubMed ID: 8644271
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between kidney living donor and cadaveric donor transplantations in recipients below 45 years of age.
    Fehrman I; Tydén G
    Transplant Proc; 1992 Feb; 24(1):330. PubMed ID: 1539298
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of donor age on kidney graft function and on histopathological findings.
    Isoniemi H; von Willebrand E; Krogerus L; Taskinen E; Ahonen J; Häyry P
    Transplant Proc; 1992 Feb; 24(1):328-9. PubMed ID: 1539296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.